We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, a... read more Featured Products: More products

Download Mobile App




Malaria Rapid Test Evaluated in Low Transmission Area

By LabMedica International staff writers
Posted on 23 Aug 2017
Print article
Image: The CareStart rapid diagnostic tests for malaria (Photo courtesy of Access Bio).
Image: The CareStart rapid diagnostic tests for malaria (Photo courtesy of Access Bio).
Light microscopy detecting human malarial parasites in Giemsa-stained thick and thin blood films still remains the gold standard for malaria diagnosis. In many peripheral health centers of endemic countries, microscopy is not available due to limited resources or lack of expertise.

Malaria rapid diagnostic tests (RDTs), based on immunochromatographic parasite antigen detection, are of great value in endemic regions. However, it remains unclear whether RDTs are useful in field conditions in low transmission areas since their reliability is limited by the lack of detection of low-density parasitemia.

Scientists at Cheikh Anta Diop University (Dakar, Senegal) enrolled 215 patients suspected of malaria in two peri-urban area of Dakar. Blood samples were collected for RDT and microscopy, and a filter paper collected for polymerase chain reaction (PCR). Inclusion criterion for this study was individuals with fever and suspicion of malaria and without clinical sign of severe malaria.

The team made both thick and thin films were made in the same slide which were stained and examined. Finger prick blood sample were tested for malaria parasites using CareStart Malaria HRP2/pLDH Combo Test in the field. CareStart RDT is an immunochromatographic test coated with monoclonal antibodies in two separate bands, one recognizing the specific histidine-rich protein-2 (HRP-2) associated with the presence of Plasmodium falciparum and the other detecting presence of pan malaria-specific antigen (pLDH) of all malarial parasites species. The real-time PCR assay, known as photo-induced electron transfer (PET)-PCR, was also performed.

The investigators reported that when considering PCR as the gold standard, CareStart RDT showed high sensitivity (97.3%) and specificity (94.1%) with a positive predictive value (PPV) and negative predictive value (NPV) of 97.3% and 94.1%, respectively. Microscopy had a sensitivity of 93.2% and specificity of 100%, and PPV and NPV of 100% and 87.2%, respectively. CareStart RDT showed less false negative but more false positive results compared to microscopy.

The authors concluded that although RDT usefulness in low transmission areas or in the detection of low parasite density infections is being questioned, CareStart RDT showed good sensitivity comparable to that performed by expert microscopist. However, in the wake of reported HRP2 deletion in other countries, microscopy should always accompany the use of RDT. Combination of RDT and microscopy together with the evaluation of malaria RDTs over time should be a powerful tool for diagnosing malaria in endemic countries. The study was published on August 10, 2017, in the Malaria Journal.

Related Links:
Cheikh Anta Diop University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.